Global Pharmacogenetics Testing Market Research Report 2024

Publication ID:

PB505248179

Publication Date:

May 30, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Pharmacogenetics testing is a type of genetic testing that analyzes an individual's genetic makeup to determine how they may respond to certain medications. It involves studying the variations in genes that affect drug metabolism, efficacy, and potential side effects.
Pharmacogenetics testing can provide valuable information to healthcare professionals in determining the most effective and safe medications for a particular individual. By understanding an individual's genetic variations, doctors can tailor drug prescriptions to match their specific genetic profile, potentially improving treatment outcomes and reducing the risk of adverse drug reactions.
This type of testing is particularly useful in determining the appropriate dosage of medications, predicting the likelihood of adverse drug reactions, and identifying individuals who may be poor responders to certain drugs. It can also help avoid trial-and-error approaches to medication selection, allowing for more personalized and precise treatment plans.
Pharmacogenetics testing is commonly used in various medical fields, including psychiatry, cardiology, oncology, and pain management. It is especially beneficial for medications with a narrow therapeutic index, where small variations in drug metabolism can significantly impact treatment outcomes.
The global Pharmacogenetics Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmacogenetics Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacogenetics Testing.
Report Scope
The Pharmacogenetics Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmacogenetics Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmacogenetics Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Genetworx
ARUP Laboratories
Labcorp
Invitae
Clinical Labs
Abomics
Gravity Diagnostics
Carolina Pharmacy
Kailos Genetics
Fulgent Genetics
Segment by Type
Dosage Selection
Adverse Reaction Assessment
Segment by Application
Enterprise
Government
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmacogenetics Testing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacogenetics Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Dosage Selection
1.2.3 Adverse Reaction Assessment
1.3 Market by Application
1.3.1 Global Pharmacogenetics Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Enterprise
1.3.3 Government
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmacogenetics Testing Market Perspective (2019-2030)
2.2 Pharmacogenetics Testing Growth Trends by Region
2.2.1 Global Pharmacogenetics Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmacogenetics Testing Historic Market Size by Region (2019-2024)
2.2.3 Pharmacogenetics Testing Forecasted Market Size by Region (2025-2030)
2.3 Pharmacogenetics Testing Market Dynamics
2.3.1 Pharmacogenetics Testing Industry Trends
2.3.2 Pharmacogenetics Testing Market Drivers
2.3.3 Pharmacogenetics Testing Market Challenges
2.3.4 Pharmacogenetics Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacogenetics Testing Players by Revenue
3.1.1 Global Top Pharmacogenetics Testing Players by Revenue (2019-2024)
3.1.2 Global Pharmacogenetics Testing Revenue Market Share by Players (2019-2024)
3.2 Global Pharmacogenetics Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmacogenetics Testing Revenue
3.4 Global Pharmacogenetics Testing Market Concentration Ratio
3.4.1 Global Pharmacogenetics Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacogenetics Testing Revenue in 2023
3.5 Pharmacogenetics Testing Key Players Head office and Area Served
3.6 Key Players Pharmacogenetics Testing Product Solution and Service
3.7 Date of Enter into Pharmacogenetics Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacogenetics Testing Breakdown Data by Type
4.1 Global Pharmacogenetics Testing Historic Market Size by Type (2019-2024)
4.2 Global Pharmacogenetics Testing Forecasted Market Size by Type (2025-2030)
5 Pharmacogenetics Testing Breakdown Data by Application
5.1 Global Pharmacogenetics Testing Historic Market Size by Application (2019-2024)
5.2 Global Pharmacogenetics Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmacogenetics Testing Market Size (2019-2030)
6.2 North America Pharmacogenetics Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmacogenetics Testing Market Size by Country (2019-2024)
6.4 North America Pharmacogenetics Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmacogenetics Testing Market Size (2019-2030)
7.2 Europe Pharmacogenetics Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmacogenetics Testing Market Size by Country (2019-2024)
7.4 Europe Pharmacogenetics Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacogenetics Testing Market Size (2019-2030)
8.2 Asia-Pacific Pharmacogenetics Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmacogenetics Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmacogenetics Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmacogenetics Testing Market Size (2019-2030)
9.2 Latin America Pharmacogenetics Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmacogenetics Testing Market Size by Country (2019-2024)
9.4 Latin America Pharmacogenetics Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacogenetics Testing Market Size (2019-2030)
10.2 Middle East & Africa Pharmacogenetics Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmacogenetics Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmacogenetics Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Genetworx
11.1.1 Genetworx Company Detail
11.1.2 Genetworx Business Overview
11.1.3 Genetworx Pharmacogenetics Testing Introduction
11.1.4 Genetworx Revenue in Pharmacogenetics Testing Business (2019-2024)
11.1.5 Genetworx Recent Development
11.2 ARUP Laboratories
11.2.1 ARUP Laboratories Company Detail
11.2.2 ARUP Laboratories Business Overview
11.2.3 ARUP Laboratories Pharmacogenetics Testing Introduction
11.2.4 ARUP Laboratories Revenue in Pharmacogenetics Testing Business (2019-2024)
11.2.5 ARUP Laboratories Recent Development
11.3 Labcorp
11.3.1 Labcorp Company Detail
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Pharmacogenetics Testing Introduction
11.3.4 Labcorp Revenue in Pharmacogenetics Testing Business (2019-2024)
11.3.5 Labcorp Recent Development
11.4 Invitae
11.4.1 Invitae Company Detail
11.4.2 Invitae Business Overview
11.4.3 Invitae Pharmacogenetics Testing Introduction
11.4.4 Invitae Revenue in Pharmacogenetics Testing Business (2019-2024)
11.4.5 Invitae Recent Development
11.5 Clinical Labs
11.5.1 Clinical Labs Company Detail
11.5.2 Clinical Labs Business Overview
11.5.3 Clinical Labs Pharmacogenetics Testing Introduction
11.5.4 Clinical Labs Revenue in Pharmacogenetics Testing Business (2019-2024)
11.5.5 Clinical Labs Recent Development
11.6 Abomics
11.6.1 Abomics Company Detail
11.6.2 Abomics Business Overview
11.6.3 Abomics Pharmacogenetics Testing Introduction
11.6.4 Abomics Revenue in Pharmacogenetics Testing Business (2019-2024)
11.6.5 Abomics Recent Development
11.7 Gravity Diagnostics
11.7.1 Gravity Diagnostics Company Detail
11.7.2 Gravity Diagnostics Business Overview
11.7.3 Gravity Diagnostics Pharmacogenetics Testing Introduction
11.7.4 Gravity Diagnostics Revenue in Pharmacogenetics Testing Business (2019-2024)
11.7.5 Gravity Diagnostics Recent Development
11.8 Carolina Pharmacy
11.8.1 Carolina Pharmacy Company Detail
11.8.2 Carolina Pharmacy Business Overview
11.8.3 Carolina Pharmacy Pharmacogenetics Testing Introduction
11.8.4 Carolina Pharmacy Revenue in Pharmacogenetics Testing Business (2019-2024)
11.8.5 Carolina Pharmacy Recent Development
11.9 Kailos Genetics
11.9.1 Kailos Genetics Company Detail
11.9.2 Kailos Genetics Business Overview
11.9.3 Kailos Genetics Pharmacogenetics Testing Introduction
11.9.4 Kailos Genetics Revenue in Pharmacogenetics Testing Business (2019-2024)
11.9.5 Kailos Genetics Recent Development
11.10 Fulgent Genetics
11.10.1 Fulgent Genetics Company Detail
11.10.2 Fulgent Genetics Business Overview
11.10.3 Fulgent Genetics Pharmacogenetics Testing Introduction
11.10.4 Fulgent Genetics Revenue in Pharmacogenetics Testing Business (2019-2024)
11.10.5 Fulgent Genetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Genetworx
ARUP Laboratories
Labcorp
Invitae
Clinical Labs
Abomics
Gravity Diagnostics
Carolina Pharmacy
Kailos Genetics
Fulgent Genetics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂